Nanjing aimeifei Biomedical Technology Co., Ltd
艾美斐
Nanjing aimeifei Biomedical Technology Co., Ltd
Biotech/Healthcare
The company develops novel small- and large-molecule drugs against globally leading targets for major diseases, including cancer, autoimmune disorders, metabolic diseases, and neurodegenerative diseases. Aimeifei Pharmaceuticals has established both small- and large-molecule drug discovery…
Latest round: Series B Extension (2024)
Source: ChinaBulls — chinabulls.com
Last updated 2024-11-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.